The qualification certification of science and technology research and development institutions in Changping District is an advanced measure taken by the Science and Technology Committee of Changping District to further implement the strategy of rejuvenating the country through science and education, the strategy of strengthening the country through talent and the strategy of innovation-driven development, guide and encourage innovation subjects to carry out the construction of science and technology research and development institutions, and enhance regional innovation ability.

Beijing Haiyan is the only R&D and production wholly-owned subsidiary of Yangzijiang Pharmaceutical Group in the north. Founded in 2004, the company is located in Beijing Zhongguancun Life Science Park. The company attaches great importance to innovation and research and development. At present, the main products on the market include Suhuang cough capsule, Irbesartan tablet, racecadotril tablet, Rizatriptan benzoate tablet, etc., and have formed advantages in respiratory system and cardiovascular field. Suhuang cough capsule and Erbei tablet have obtained Beijing New Technology and new product (service) certificate.

This recognition is the Changping District Science and Technology Committee's full affirmation of Beijing Haiyan's R & D platform and R & D capability, the company adheres to the quality and benefit oriented development road, actively conforms to the national development of medicine and health field, adhering to the quality spirit of "no difficulty can not bring us down, only quality", forge ahead, never satisfied, and take "to be China's strongest and world-class pharmaceutical enterprise" as the vision. To meet the people's yearning for a better life and contribute to the development of people's medicine and health.